Fatal encephalopathy with wild‐type JC virus and ruxolitinib therapy

JC virus (JCV) infection is a lytic infection of oligodendrocytes in progressive multifocal leukoencephalopathy; less common forms of central nervous system manifestations associated with JCV infection include granule cell neuronopathy, encephalopathy, and meningitis. Presented is the first case of fatal JCV encephalopathy after immunosuppressive therapy that included ruxolitinib.

[1]  D. Milojković,et al.  Progressive multifocal leukoencephalopathy associated with ruxolitinib. , 2013, The New England journal of medicine.

[2]  J. Gordon,et al.  JC Virus Encephalopathy Is Associated with a Novel Agnoprotein-Deletion JCV Variant , 2012, PloS one.

[3]  J. Kopp,et al.  Conditionally immortalized human podocyte cell lines established from urine. , 2010, American journal of physiology. Renal physiology.

[4]  V. Martín,et al.  Fatal ruxolitinib-related JC virus meningitis , 2017, Journal of NeuroVirology.

[5]  L. Ngo,et al.  JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. , 2012, The Journal of general virology.

[6]  S. Holland,et al.  Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.